Franco-Indian Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 4.63 M
as on 17-11-2024
- Company Age 65 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 3.15%
(FY 2023)
- Profit 30.66%
(FY 2023)
- Ebitda 22.09%
(FY 2023)
- Net Worth 17.09%
(FY 2023)
- Total Assets 6.95%
(FY 2023)
About Franco-Indian Pharmaceuticals
The Corporate was formerly known as Franco-Indian Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 4.63 M, as per Ministry of Corporate Affairs (MCA) records.
Pascal Postel, Errol Desouza, Jagdish Mehta, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24239MH1959PTC011347
- Company No.
011347
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 May 1959
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Franco-Indian Pharmaceuticals Private Limited offer?
Franco-Indian Pharmaceuticals Private Limited offers a wide range of products and services, including Women Care, Mother Care, Health Conditions, Liver Care, Piles, Fissures & Fistula, Heart Care.
Who are the key members and board of directors at Franco-Indian Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pascal Postel  | Managing Director | 01-Jan-1998 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santosh Chavan | Director | 09-Mar-2021 | Current |
| Errol Desouza | Director | 01-Mar-2023 | Current |
| Jagdish Mehta | Director | 19-Mar-2014 | Current |
| Lalsa Yadav | Director | 05-Aug-2005 | Current |
| Alexandre Postel | Director | 05-Jan-2023 | Current |
| Ajit Mangalvede | Director | 02-May-2023 | Current |
Financial Performance of Franco-Indian Pharmaceuticals.
Franco-Indian Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.15% increase. The company also saw a substantial improvement in profitability, with a 30.66% increase in profit. The company's net worth Soared by an impressive increase of 17.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Franco-Indian Pharmaceuticals?
In 2023, Franco-Indian Pharmaceuticals had a promoter holding of 48.99% and a public holding of 51.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Franco Indian Medicare Pvt LtdActive 41 years 6 monthsPascal Postel and Lalsa Yadav are mutual person
- Franco Indian Therapeutics Pvt. Ltd.Active 38 years 7 months
Pascal Postel and Lalsa Yadav are mutual person
- Wardex Pharmaceuticals Private LimitedActive 78 years 5 days
Pascal Postel, Jagdish Mehta and 1 more are mutual person
- Franco Indian Research Private LimitedActive 51 years 9 months
Pascal Postel and Lalsa Yadav are mutual person
Princeps Pharmaceuticals Private LimitedActive 24 years 8 monthsPascal Postel and Lalsa Yadav are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Franco-Indian Pharmaceuticals?
Franco-Indian Pharmaceuticals has a workforce of 1524 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Franco-Indian Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Franco-Indian Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
